ESE vs VRTX · P/E 57, rev $1.10B vs P/E 30, rev $12.00B
ESCO Technologies Inc (ESE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
ESCO Technologies Inc (ESE) is a scientific & technical instruments company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ESE revenue for 2025-09-30 was $1.10B. Net income was $299.2M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. ESE currently screens at market cap $7.58B and trailing P/E 57.5.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ESE currently screens at market cap $7.58B and trailing P/E 57.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ESE and VRTX stock pages for the full models.
Not investment advice.